Godwin T F, Gunton R W
Can Med Assoc J. 1965 Dec 18;93(25):1296-300.
A clinical trial was carried out with the object of comparing the effects of furosemide, a new oral diuretic agent, with those of mercaptomerin and hydrochlorothiazide. Eleven edematous patients were chosen for the study and the diuretics were rotated, each drug being preceded by a one- to three-day control period. The patients served as their own controls. Urine electrolytes, body weight, and blood chemistry were monitored.Furosemide was shown to be an effective diuretic in this clinical study; under the conditions of the trial a single oral dose of 80 mg. of furosemide produced a natriuretic response in a 24-hour period equivalent to that achieved with a single oral dose of 100 mg. of hydrochlorothiazide or a single dose of 2.0 c.c. (80 mg. of mercury) of mercaptomerin given intramuscularly.
进行了一项临床试验,目的是比较新型口服利尿剂速尿与汞撒利和氢氯噻嗪的效果。选择了11名水肿患者进行研究,利尿剂轮流使用,每种药物使用前有1至3天的对照期。患者自身作为对照。监测尿电解质、体重和血液化学指标。在这项临床研究中,速尿被证明是一种有效的利尿剂;在试验条件下,单次口服80毫克速尿在24小时内产生的排钠反应与单次口服100毫克氢氯噻嗪或单次肌肉注射2.0毫升(80毫克汞)汞撒利所产生的排钠反应相当。